Product Information
TRIFLUOPERAZINE 5 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.8947 per EA under NDC 00378240501. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
5 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378240501
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TRIFLUOPERAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040209On Market Since
8/29/1997
Pharmacological Classes
Price Statistics
The NADAC for TRIFLUOPERAZINE 5 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 114.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8947 per EA |
|---|---|
| All-time high | $1.2797 (Apr 15, 2015) |
| All-time low | $0.4172 (Nov 28, 2013) |
| 52-week high | $0.8947 |
| 52-week low | $0.7087 |
| Median price | $0.9424 |
| Average price | $0.9248 |
| Largest weekly change | +109.5% (Dec 18, 2013) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRIFLUOPERAZINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRIFLUOPERAZINE 5 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.8947 per EA (NDC 00378240501), effective Jun 24, 2026.
How has the price of TRIFLUOPERAZINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRIFLUOPERAZINE 5 MG TABLET has risen 114.4%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRIFLUOPERAZINE 5 MG TABLET?
Since Nov 28, 2013, the NADAC for TRIFLUOPERAZINE 5 MG TABLET has ranged from a low of $0.4172 (Nov 28, 2013) to a high of $1.2797 (Apr 15, 2015), with a median of $0.9424 per EA.
Are there cheaper alternatives to TRIFLUOPERAZINE 5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TRIFLUOPERAZINE 5 MG TABLET, but none are currently priced below it.
Who manufactures TRIFLUOPERAZINE 5 MG TABLET?
TRIFLUOPERAZINE 5 MG TABLET (NDC 00378240501) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification